Our data demonstrate that GREM1 protein expression is upregulated in the AKP transgenic mouse model of colorectal cancer, which expresses APC/KRAS/p53 mutations commonly found in human colorectal cancer (35, 36, 37). This evidence concerns the gene TP53 and colorectal cancer.